CoChat

Alzheimer’s β‐amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR‐2

Open access
Patel, Nikunj S., Mathura, Venkatarajan S., Bachmeier, Corbin, Beaulieu‐Abdelahad, David, Laporte, Vincent, Weeks, Ophelia, Mullan, Michael, Paris, Daniel · 2010 · Journal of Neurochemistry
Cited by 99

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

J. Neurochem. (2010) 112, 66–76. Beta‐amyloid peptides (Aβ) are the major constituents of senile plaques and cerebrovascular deposits in the brains of Alzheimer’s disease patients. We have shown previously that soluble forms of Aβ are anti‐angiogenic both in vitro and in vivo. However, the mechanism of the anti‐angiogenic activity of Aβ peptides is unclear. In this study, we examined the effects of Aβ1–42 on vascular endothelial growth factor receptor 2 (VEGFR‐2) signaling, which plays a key role in angiogenesis. Aβ inhibited VEGF‐induced migration of endothelial cells, as well as VEGF‐induced permeability of an in vitro model of the blood brain barrier. Consistently, exogenous VEGF dose‐dependently antagonized the anti‐angiogenic activity of Aβ in a capillary network assay. Aβ1–42 also blocked VEGF‐induced tyrosine phosphorylation of VEGFR‐2 in two types of primary endothelial cells, suggesting an antagonistic action of Aβ toward VEGFR‐2 signaling in cells. Moreover, Aβ was able to directly interact with the extracellular domain of VEGFR‐2 and to compete with the binding of VEGF to its receptor in a cell‐free assay. Co‐immunoprecipitation experiments confirmed that Aβ can bind VEGFR‐2 both in vitro and in vivo. Altogether, our data suggest that Aβ acts as an antagonist of VEGFR‐2 and provide a mechanism explaining the anti‐angiogenic activity of Aβ peptides.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2009.06426.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 99

Metadata

Authors
Patel, N. S., Mathura, V. S., Bachmeier, C., Beaulieu‐Abdelahad, D., Laporte, V., Weeks, O., Mullan, M., & Paris, D.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2009-12-08
Volume
112
Issue
1
Pages
66-76
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2082120711
Cited by
99
References
8
FWCI
3.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer’s β‐amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR‐2. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06426.x
The paper
Patel, N. S., Mathura, V. S., Bachmeier, C., Beaulieu‐Abdelahad, D., Laporte, V., Weeks, O., Mullan, M., & Paris, D. (2010). Alzheimer’s β‐amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR‐2. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06426.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.